So you see Vical like you saw Nanogen (where you posted last year)?
IMO Vical is NOT a pan flu play...it's a platform play. Platforms are boring....UNTIL a path to drug approval for humans is clear. The Allovectin-7 cancer vaccine is Vical's biggest bet...where over 200 million R&D is invested.
Come back in a year and see whether Vical is on the pink sheets or in double digits.